Read articles from North America

September 01, 2026 by realclearhealth.com

A regulator can make quitting harder even while claiming to protect public health. Delayed approvals, narrow authorisation pathways and hostility towards safer nicotine products can leave adult smokers with fewer legal options than they need. Cigarettes remain widely available while alternatives that may help people switch face barriers that slow or block access. The FDA’s approach should be judged by whether it reduces smoking-related harm, not by how cautious it appears on paper.

August 31, 2026 by leaderpost.com

Saskatchewan’s nicotine pouch debate shows what happens when legal rules fail to match consumer reality. A product can be restricted on paper while still circulating through channels with weaker checks, less accountability and no clear path for adult smokers. That should concern anyone interested in youth protection or harm reduction. Regulation should bring smoke-free alternatives into a controlled market, not leave access to confusion, loopholes and illegal supply.

August 28, 2026 by substack.com

A JAMA article supporting clinician conversations about e-cigarettes should make the debate more precise. The evidence is strongest for adult smokers who use vaping as a route away from cigarettes, not for vague claims about nicotine use in general. That distinction matters because policy can either support full switching or bury it under uncertainty. Medical guidance should separate evidence from values clearly enough for smokers to understand their options.

August 27, 2026 by ocregister.com

Smokers should not have to fight bureaucracy to reach safer choices. Regulation has a role in setting standards, preventing youth access and protecting consumers, but it should not become a barrier that leaves cigarettes as the easiest product to buy. Harm reduction depends on making lower-risk alternatives available, understandable and legally viable. Public health loses its purpose when process blocks the very options that could reduce harm.

August 27, 2026 by ocregister.com

Smokers should not have to fight bureaucracy to reach safer choices. Regulation has a role in setting standards, preventing youth access and protecting consumers, but it should not become a barrier that leaves cigarettes as the easiest product to buy. Harm reduction depends on making lower-risk alternatives available, understandable and legally viable. Public health loses its purpose when process blocks the very options that could reduce harm.

August 26, 2026 by substack.com

Canada’s tobacco tax cut shows that illicit markets are not untouchable. Price matters, and extreme excise can stop working as public health policy once illegal cigarettes become the cheaper, easier option. Reducing the black market does not mean giving up on lower smoking rates; it means designing incentives that keep consumers inside legal, accountable channels. A serious strategy should combine realistic taxation, enforcement and access to safer nicotine alternatives.

August 25, 2026 by substack.com

A flavour is not an age group, and regulation becomes weaker when it treats the two as the same. Adults who smoke often rely on flavoured products because taste can make switching away from cigarettes more acceptable and sustainable. Youth access should be prevented through age checks, retailer enforcement and penalties for illegal sales, not by removing options from adults. Public health needs precision: protect young people without making harm reduction less workable for smokers.

August 24, 2026 by regulatorwatch.com

The court ruling against the FDA’s approach to flavoured vapes could mark an important turning point for evidence-based regulation. Flavours are not a minor detail for many adults who switch from smoking; they can affect whether lower-risk products are acceptable enough to replace cigarettes. Youth protection remains essential, but it should be pursued through enforcement and product standards rather than blanket hostility to adult choice. A credible regulatory system should assess risk, behaviour and public health impact instead of treating flavour as automatic failure.

August 24, 2026 by goodgoodgood.co

Historic-low youth smoking rates should be recognised as major public health progress. The latest US data also show falling youth vaping, challenging the idea that adult access to lower-risk nicotine products inevitably drives a youth crisis. Prevention still matters, especially for those who already vape frequently, but the message should be proportionate. Protecting young people and helping adult smokers leave cigarettes behind can be part of the same strategy.

August 21, 2026 by thecritic.co.uk

Nicotine policy often collapses into confusion because the central distinction is blurred. People smoke for nicotine, but they die mainly from the toxic products of combustion. Treating every nicotine product as though it carries the same risk as cigarettes makes public health advice less accurate and less useful. A clearer strategy would separate dependence from disease, protect young people and help adult smokers move away from the most harmful form of nicotine use.